Records containing: Ovarian Hyperstimulation Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-09-04ClinicalTrials.gov study NCT00365027
-
CLINICAL_TRIALS study record update · 2015-08-04An Uncontrolled, Open-label Feasibility Study to Demonstrate That a GnRH Agonist (Decapeptyl) Can be Safely Administered to Trigger Final Oocyte Maturation in High Responder Patients to Mitigate the Risk of OHSS
-
CLINICAL_TRIALS study record update · 2015-05-06Compare the Efficacy of Human Albumin With Cabergoline to Prevent of Ovarian Hyper Stimulation in ART Program
-
CLINICAL_TRIALS study record update · 2015-04-07Early Follicular Phase Androstenedione Monitoring During Low-dose Step-up Induction of Ovulation in High Responders
-
CLINICAL_TRIALS study record update · 2015-03-19GnRH Antagonist in the Luteal Phase Compared to Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) in Whom All Embryos Are Cryopreserved
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-07-29Serum Levels of IMA, TAC, TOS, OSI and MDA in Severe OHSS Patients Underwent Long Agonist Protocol Intracytoplasmic Sperm for Determining Oxidative Stress Status
-
CLINICAL_TRIALS study record update · 2014-07-09Does Intravenous Calcium Infusion Effectively Prevent OHSS : a Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2014-03-12The Use of a Long Acting GnRH Antagonist (Degarelix) in Controlled Ovarian Hyperstimulation in PCOS Women at a Risk to Developing OHSS Undergoing IVF : a Pilot Study
-
CLINICAL_TRIALS study record update · 2013-09-19Usefulness of GnRH Antagonist Administration in the Treatment of Early Ovarian Hyperstimulation Syndrome
-
CLINICAL_TRIALS study record update · 2013-03-27The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome in Oocyte Donors
-
CLINICAL_TRIALS study record update · 2012-06-14OHSS Prevention by GnRH-agonist Triggering of Final Oocyte Maturation and Cryoperservation of All Two-pronucleate Oocytes in Women Undergoing Stimulation for IVF With Gonadotrophins and GnRH-analogues: a Prospective, Observational, Multicentric, Clinical Cohort Study
-
CLINICAL_TRIALS study record update · 2012-04-04The Effect Of Cabergoline On Follicular Microenvironment Profile In Patients With High Risk Of Ohss
-
CLINICAL_TRIALS study record update · 2012-02-22The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome.
-
CLINICAL_TRIALS study record update · 2011-11-28ClinicalTrials.gov study NCT01477970
-
CLINICAL_TRIALS study record update · 2011-07-15Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome in In-vitro Fertilization Cycles: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2011-05-19A Randomised, Double-blind, Parallel Groups, Dose-finding, Placebo-controlled, Multi-centre, Proof of Concept Study Assessing the Effect of 3-wk Treatment With 1 of 3 Oral Doses of Quinagolide & Placebo in Preventing Ovarian Hyperstimulation Syndrome in Women Undergoing Controlled Ovarian Hyperstimulation.
-
CLINICAL_TRIALS study record update · 2009-09-17A Randomised, Double-blind, Parallel Groups, Placebo-controlled, Single-centre Pilot Study Assessing the Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome
-
CLINICAL_TRIALS study record update · 2008-12-17ClinicalTrials.gov study NCT00480337
-
CLINICAL_TRIALS study record update · 2008-10-29Cost Effectiveness of Two Different Strategies to Implement the NVOG Guideline Programme on Subfertility
-
CLINICAL_TRIALS study record update · 2007-02-27Dopamine Agonist Cabergoline Reduces Hemoconcentration and Ascites in Hyperstimulated Women Undergoing Assisted Reproduction.
-
CLINICAL_TRIALS study record update · 2006-12-29Randomized Controlled Trial Comparing the Effect of GnRH Agonist and Antagonist Ovarian Stimulation Protocols in PCOS Patients
-
CLINICAL_TRIALS study record update · 2006-07-06A Prospective Randomized Study Comparing the Use of hCG or GnRH Agonist to Trigger Final Oocyte Maturation in High Responders Undergoing in-Vitro Fertilization Treatment